Literature DB >> 17517861

Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection.

Erin C Hagan1, Harry L T Mobley.   

Abstract

Uncomplicated urinary tract infection (UTI) caused by uropathogenic Escherichia coli (UPEC) represents a prevalent and potentially severe infectious disease. In this study, we describe the application of an immunoproteomics approach to vaccine development that has been used successfully to identify vaccine targets in other pathogenic bacteria. Outer membranes were isolated from pyelonephritis strain E. coli CFT073 cultured under conditions that mimic the urinary tract environment, including iron limitation, osmotic stress, human urine, and exposure to uroepithelial cells. To identify antigens that elicit a humoral response during experimental UTI, outer membrane proteins were separated by two-dimensional gel electrophoresis and probed using pooled antisera from 20 CBA/J mice chronically infected with E. coli CFT073. In total, 23 outer membrane antigens, including a novel iron compound receptor, reacted with the antisera and were identified by mass spectrometry. These antigens also included proteins with known roles in UPEC pathogenesis, such as ChuA, IroN, IreA, Iha, IutA, and FliC. These data demonstrate that an antibody response is directed against these virulence-associated factors during UTI. We also show that the genes encoding ChuA, IroN, hypothetical protein c2482, and IutA are significantly more prevalent (P < 0.01) among UPEC strains than among fecal-commensal E. coli isolates. Thus, we suggest that the conserved outer membrane antigens identified in this study could be rational candidates for a UTI vaccine designed to elicit protective immunity against UPEC infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17517861      PMCID: PMC1951972          DOI: 10.1128/IAI.00337-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

1.  Purification of the Escherichia coli type 1 pilin and minor pilus proteins and partial characterization of the adhesin protein.

Authors:  M S Hanson; J Hempel; C C Brinton
Journal:  J Bacteriol       Date:  1988-08       Impact factor: 3.490

2.  Proteomic analysis of the Escherichia coli outer membrane.

Authors:  M P Molloy; B R Herbert; M B Slade; T Rabilloud; A S Nouwens; K L Williams; A A Gooley
Journal:  Eur J Biochem       Date:  2000-05

3.  Genetic and metabolic control of enzymes responsible for histidine degradation in Salmonella typhimurium. 4-imidazolone-5-propionate amidohydrolase and N-formimino-L-glutamate formiminohydrolase.

Authors:  G R Smith; Y S Halpern; B Magasanik
Journal:  J Biol Chem       Date:  1971-05-25       Impact factor: 5.157

4.  Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis.

Authors:  P O'Hanley; G Lalonde; G Ji
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

5.  Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women.

Authors:  A Stapleton; S Moseley; W E Stamm
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

6.  Haemolysin contributes to virulence of extra-intestinal E. coli infections.

Authors:  R A Welch; E P Dellinger; B Minshew; S Falkow
Journal:  Nature       Date:  1981-12-17       Impact factor: 49.962

7.  Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

Authors:  M Pizza; V Scarlato; V Masignani; M M Giuliani; B Aricò; M Comanducci; G T Jennings; L Baldi; E Bartolini; B Capecchi; C L Galeotti; E Luzzi; R Manetti; E Marchetti; M Mora; S Nuti; G Ratti; L Santini; S Savino; M Scarselli; E Storni; P Zuo; M Broeker; E Hundt; B Knapp; E Blair; T Mason; H Tettelin; D W Hood; A C Jeffries; N J Saunders; D M Granoff; J C Venter; E R Moxon; G Grandi; R Rappuoli
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

8.  Transcriptome of uropathogenic Escherichia coli during urinary tract infection.

Authors:  Jennifer A Snyder; Brian J Haugen; Eric L Buckles; C Virginia Lockatell; David E Johnson; Michael S Donnenberg; Rodney A Welch; Harry L T Mobley
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

9.  Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains.

Authors:  H L Mobley; D M Green; A L Trifillis; D E Johnson; G R Chippendale; C V Lockatell; B D Jones; J W Warren
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

10.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.

Authors:  L Hagberg; I Engberg; R Freter; J Lam; S Olling; C Svanborg Edén
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

View more
  64 in total

1.  Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins.

Authors:  Koushik Roy; Scott Bartels; Firdausi Qadri; James M Fleckenstein
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

2.  Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation.

Authors:  Viktoria Hancock; Rebecca Munk Vejborg; Per Klemm
Journal:  Mol Genet Genomics       Date:  2010-10-01       Impact factor: 3.291

3.  Immunoproteomic analysis to identify Shiga toxin-producing Escherichia coli outer membrane proteins expressed during human infection.

Authors:  David Montero; Paz Orellana; Daniela Gutiérrez; Daniela Araya; Juan Carlos Salazar; Valeria Prado; Angel Oñate; Felipe Del Canto; Roberto Vidal
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

4.  Survival of uropathogenic Escherichia coli in the murine urinary tract is dependent on OmpR.

Authors:  William R Schwan
Journal:  Microbiology (Reading)       Date:  2009-04-21       Impact factor: 2.777

5.  Trade-off between iron uptake and protection against oxidative stress: deletion of cueO promotes uropathogenic Escherichia coli virulence in a mouse model of urinary tract infection.

Authors:  Jai J Tree; Glen C Ulett; Cheryl-Lynn Y Ong; Darren J Trott; Alastair G McEwan; Mark A Schembri
Journal:  J Bacteriol       Date:  2008-08-22       Impact factor: 3.490

6.  OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis.

Authors:  Tracy F Nicholson; Kristin M Watts; David A Hunstad
Journal:  Infect Immun       Date:  2009-09-21       Impact factor: 3.441

7.  Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence.

Authors:  Patrick D Vigil; Christopher J Alteri; Harry L T Mobley
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

8.  Host-specific induction of Escherichia coli fitness genes during human urinary tract infection.

Authors:  Sargurunathan Subashchandrabose; Tracy H Hazen; Ariel R Brumbaugh; Stephanie D Himpsl; Sara N Smith; Robert D Ernst; David A Rasko; Harry L T Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

9.  The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection.

Authors:  Kelsey E Sivick; Matthew A Schaller; Sara N Smith; Harry L T Mobley
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

10.  Mucosal immunization with iron receptor antigens protects against urinary tract infection.

Authors:  Christopher J Alteri; Erin C Hagan; Kelsey E Sivick; Sara N Smith; Harry L T Mobley
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.